Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors

Purpose This phase I study evaluated the safety, tolerability, maximum tolerated dose (MTD), and recommended phase II dose (RP2D) of tivantinib combined with sorafenib in patients with advanced solid tumors. Materials and Methods A standard 3 + 3 dose escalation design was used. At the RP2D, expansi...

Descripción completa

Detalles Bibliográficos
Autores principales: Puzanov, Igor, Sosman, Jeffrey, Santoro, Armando, Saif, Muhammad W., Goff, Laura, Dy, Grace K., Zucali, Paolo, Means-Powell, Julie A., Ma, Wen Wee, Simonelli, Matteo, Martell, Robert, Chai, Feng, Lamar, Maria, Savage, Ronald E., Schwartz, Brian, Adjei, Alex A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Phase I Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295023/
https://www.ncbi.nlm.nih.gov/pubmed/25294187
http://dx.doi.org/10.1007/s10637-014-0167-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295023/
https://www.ncbi.nlm.nih.gov/pubmed/25294187
http://dx.doi.org/10.1007/s10637-014-0167-5

Ejemplares similares